Bioprocessing Unfiltered

CHI
  • 5.0 (1)
  • LIFE SCIENCES

Covering both upstream and downstream processing, analytics, AI and digitization, cell and gene therapy and more, Bioprocessing Unfiltered is your insider’s pass to the researchers tackling—and solving—the day-to-day challenges in the bioprocessing industry.

Episodes

  1. Episode: 4 - Andrew Sinclair Offers Insight on Optimizing Manufacturing and Operations - Part 1

    JAN 6

    Episode: 4 - Andrew Sinclair Offers Insight on Optimizing Manufacturing and Operations - Part 1

    How can we optimize manufacturing and operations? In this episode of Bioprocessing Unfiltered, Andrew Sinclair, president and founder of Biopharm Services, provides insight from his 35-year-long career in the industry on the most significant ways data management and predictive modeling can improve efficiency during the manufacturing process. With host William Whitford, founder of Oamaru BioSystems, Sinclair delves into the history and impact of costs, how to handle evolving efficiencies, and why understanding definitions can be useful for speaking the language of regulators and rating organizations. Links from this episode: Bioprocessing Summit Biopharm Services  Bioprocessing Unfiltered: Covering both upstream and downstream processing, analytics, AI and digitization, cell and gene therapy and more, Bioprocessing Unfiltered is your insider’s pass to the researchers tackling—and solving—the day-to-day challenges in the bioprocessing industry.

    23 min
  2. Episode: 3 - The Future of Gene Therapies and CDMOs with Philip Ramsey

    12/02/2025

    Episode: 3 - The Future of Gene Therapies and CDMOs with Philip Ramsey

    What is the future of gene therapies? In this episode of Bioprocessing Unfiltered, host Susan D’Costa, chief technical and commercial officer of Genezen, and Phillip Ramsey, CTO of Sangamo Therapeutics, discuss a variety of topics about gene therapies, including what will transform viral vector gene therapy, the evolving role of contract development and manufacturing organizations (CDMOs), and how gene editing in general fits into the broader gene therapy landscape. Plus, they cover the three key factors that are important in a relationship with a CDMO and the onslaught of different pressures that cell and gene therapies are currently under—and how to rekindle confidence in managing that pressure and tackling challenges.  Links from this episode:   Bioprocessing Summit Genezen Sangamo Therapeutics  Bioprocessing Unfiltered: Covering both upstream and downstream processing, analytics, AI and digitization, cell and gene therapy and more, Bioprocessing Unfiltered is your insider’s pass to the researchers tackling—and solving—the day-to-day challenges in the bioprocessing industry.

    35 min
  3. Episode: 2 - Georges Belfort Discusses Breakthroughs in mRNA Purification

    11/04/2025

    Episode: 2 - Georges Belfort Discusses Breakthroughs in mRNA Purification

    What makes mRNA purification different from other bioprocessing methods? In this episode of Bioprocessing Unfiltered, host Alois Jungbauer, professor and head of biotechnology at the Institute of Bioprocess Science and Engineering at BOKU University, speaks with Georges Belfort, institute professor of chemical and biological engineering at Rensselaer Polytechnic Institute about his research in mRNA purification and his long, illustrious career in the industry, including the impact of his discoveries, the challenges encountered, and the lessons learned along the way. He also shares how he translates his research into products, what his lab is working on, and navigating competition from other companies.  Links from this episode:   Bioprocessing Summit RPI Chemical & Biological Engineering Rensselaer Polytechnic Institute BOKU University Institute of Bioprocess Science and Engineering BOKU University    Bioprocessing Unfiltered: Covering both upstream and downstream processing, analytics, AI and digitization, cell and gene therapy and more, Bioprocessing Unfiltered is your insider’s pass to the researchers tackling—and solving—the day-to-day challenges in the bioprocessing industry.

    33 min
  4. Episode: 1 - Bo Wiinberg on Bridging Research and Trials with Cell-Based Therapies

    10/03/2025

    Episode: 1 - Bo Wiinberg on Bridging Research and Trials with Cell-Based Therapies

    Are cell therapies the key to bridging the gap between discovery research and clinical trials? In the inaugural episode of the Bioprocessing Unfiltered podcast, Bo Wiinberg, chief business development officer at Novo Nordisk Foundation Cellerator, sat with Ran Zheng, CEO of Landmark Bio and shared his expert insight on the promise cell therapies hold for diseases with only treatments but no cures. Their conversation covers the challenges of navigating cell therapy programs through pre-clinical and clinical development journeys, how Cellerator is creating innovative spaces in CMC and manufacturing to fulfill critical needs in the translational space, and what a sustainable global cell therapy manufacturing landscape looks in 5-10 years.  Links from this episode:   Bioprocessing Summit Landmark Bio Novo Nordisk Foundation Cellerator  Bioprocessing Unfiltered: Covering both upstream and downstream processing, analytics, AI and digitization, cell and gene therapy and more, Bioprocessing Unfiltered is your insider’s pass to the researchers tackling—and solving—the day-to-day challenges in the bioprocessing industry.

    22 min
  • 4 Episodes

Ratings & Reviews

About

Covering both upstream and downstream processing, analytics, AI and digitization, cell and gene therapy and more, Bioprocessing Unfiltered is your insider’s pass to the researchers tackling—and solving—the day-to-day challenges in the bioprocessing industry.

Information

  • Creator
    CHI
  • Years Active
    2025 - 2026
  • Episodes
    4
  • Rating
    Clean
  • Copyright
    © 2026 Bioprocessing Unfiltered
  • Show Website
    Bioprocessing Unfiltered